Global and Japan Weight Loss Drugs Market Insights, Forecast to 2026

Publisher Name :
Date: 16-Oct-2020
No. of pages: 144
Inquire Before Buying

Weight Loss Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Weight Loss Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Weight Loss Drugs market is segmented into

- Liauid

- Tablets

Segment by Application, the Weight Loss Drugs market is segmented into

- Weight-reducing Aid

- Other

Regional and Country-level Analysis

The Weight Loss Drugs market is analysed and market size information is provided by regions (countries).

The key regions covered in the Weight Loss Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Weight Loss Drugs Market Share Analysis

Weight Loss Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Weight Loss Drugs business, the date to enter into the Weight Loss Drugs market, Weight Loss Drugs product introduction, recent developments, etc.

The major vendors covered:

- Roche

- GSK group

- Teva

- Sandoz(Novartis)

- STADA-VN J.V.Co., Ltd

- Hexal AG

- National Company For Pharmaceutical Industry

- Lunan Pharmaceutical Group Corporation

- Zein Pharmaceutical

- Hisun

- Taj Pharmaceuticals Ltd

- Kabir Life Sciences & Research

- Dm Pharma

- China Zhongshan Pharm

Global and Japan Weight Loss Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Weight Loss Drugs Product Introduction
1.2 Market Segments
1.3 Key Weight Loss Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Weight Loss Drugs Market Size Growth Rate by Type
1.4.2 Liauid
1.4.3 Tablets
1.5 Market by Application
1.5.1 Global Weight Loss Drugs Market Size Growth Rate by Application
1.5.2 Weight-reducing Aid
1.5.3 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Weight Loss Drugs Market Size, Estimates and Forecasts
2.1.1 Global Weight Loss Drugs Revenue 2015-2026
2.1.2 Global Weight Loss Drugs Sales 2015-2026
2.2 Global Weight Loss Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Weight Loss Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Weight Loss Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Weight Loss Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Weight Loss Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Weight Loss Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Weight Loss Drugs Revenue Forecast by Region (2021-2026)
3 Global Weight Loss Drugs Competitor Landscape by Players
3.1 Global Top Weight Loss Drugs Sales by Manufacturers
3.1.1 Global Weight Loss Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Weight Loss Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Weight Loss Drugs Manufacturers by Revenue
3.2.1 Global Weight Loss Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Weight Loss Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Weight Loss Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Weight Loss Drugs Revenue in 2019
3.2.5 Global Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Weight Loss Drugs Price by Manufacturers
3.4 Global Weight Loss Drugs Manufacturing Base Distribution, Product Types
3.4.1 Weight Loss Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Weight Loss Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Weight Loss Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Weight Loss Drugs Market Size by Type (2015-2020)
4.1.1 Global Weight Loss Drugs Sales by Type (2015-2020)
4.1.2 Global Weight Loss Drugs Revenue by Type (2015-2020)
4.1.3 Weight Loss Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Weight Loss Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Weight Loss Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Weight Loss Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Weight Loss Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Weight Loss Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Weight Loss Drugs Market Size by Application (2015-2020)
5.1.1 Global Weight Loss Drugs Sales by Application (2015-2020)
5.1.2 Global Weight Loss Drugs Revenue by Application (2015-2020)
5.1.3 Weight Loss Drugs Price by Application (2015-2020)
5.2 Weight Loss Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Weight Loss Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Weight Loss Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Weight Loss Drugs Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Weight Loss Drugs Market Size YoY Growth 2015-2026
6.1.1 Japan Weight Loss Drugs Sales YoY Growth 2015-2026
6.1.2 Japan Weight Loss Drugs Revenue YoY Growth 2015-2026
6.1.3 Japan Weight Loss Drugs Market Share in Global Market 2015-2026
6.2 Japan Weight Loss Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Weight Loss Drugs Players by Sales (2015-2020)
6.2.2 Japan Top Weight Loss Drugs Players by Revenue (2015-2020)
6.3 Japan Weight Loss Drugs Historic Market Review by Type (2015-2020)
6.3.1 Japan Weight Loss Drugs Sales Market Share by Type (2015-2020)
6.3.2 Japan Weight Loss Drugs Revenue Market Share by Type (2015-2020)
6.3.3 Japan Weight Loss Drugs Price by Type (2015-2020)
6.4 Japan Weight Loss Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Weight Loss Drugs Sales Forecast by Type (2021-2026)
6.4.2 Japan Weight Loss Drugs Revenue Forecast by Type (2021-2026)
6.4.3 Japan Weight Loss Drugs Price Forecast by Type (2021-2026)
6.5 Japan Weight Loss Drugs Historic Market Review by Application (2015-2020)
6.5.1 Japan Weight Loss Drugs Sales Market Share by Application (2015-2020)
6.5.2 Japan Weight Loss Drugs Revenue Market Share by Application (2015-2020)
6.5.3 Japan Weight Loss Drugs Price by Application (2015-2020)
6.6 Japan Weight Loss Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Weight Loss Drugs Sales Forecast by Application (2021-2026)
6.6.2 Japan Weight Loss Drugs Revenue Forecast by Application (2021-2026)
6.6.3 Japan Weight Loss Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Weight Loss Drugs Market Size YoY Growth 2015-2026
7.2 North America Weight Loss Drugs Market Facts & Figures by Country
7.2.1 North America Weight Loss Drugs Sales by Country (2015-2020)
7.2.2 North America Weight Loss Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Weight Loss Drugs Market Size YoY Growth 2015-2026
8.2 Europe Weight Loss Drugs Market Facts & Figures by Country
8.2.1 Europe Weight Loss Drugs Sales by Country
8.2.2 Europe Weight Loss Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Weight Loss Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Weight Loss Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Weight Loss Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Weight Loss Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Weight Loss Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Weight Loss Drugs Market Facts & Figures by Country
10.2.1 Latin America Weight Loss Drugs Sales by Country
10.2.2 Latin America Weight Loss Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Weight Loss Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Weight Loss Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Weight Loss Drugs Sales by Country
11.2.2 Middle East and Africa Weight Loss Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Roche
12.1.1 Roche Corporation Information
12.1.2 Roche Description and Business Overview
12.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Roche Weight Loss Drugs Products Offered
12.1.5 Roche Recent Development
12.2 GSK group
12.2.1 GSK group Corporation Information
12.2.2 GSK group Description and Business Overview
12.2.3 GSK group Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK group Weight Loss Drugs Products Offered
12.2.5 GSK group Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Description and Business Overview
12.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Weight Loss Drugs Products Offered
12.3.5 Teva Recent Development
12.4 Sandoz(Novartis)
12.4.1 Sandoz(Novartis) Corporation Information
12.4.2 Sandoz(Novartis) Description and Business Overview
12.4.3 Sandoz(Novartis) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sandoz(Novartis) Weight Loss Drugs Products Offered
12.4.5 Sandoz(Novartis) Recent Development
12.5 STADA-VN J.V.Co., Ltd
12.5.1 STADA-VN J.V.Co., Ltd Corporation Information
12.5.2 STADA-VN J.V.Co., Ltd Description and Business Overview
12.5.3 STADA-VN J.V.Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
12.5.4 STADA-VN J.V.Co., Ltd Weight Loss Drugs Products Offered
12.5.5 STADA-VN J.V.Co., Ltd Recent Development
12.6 Hexal AG
12.6.1 Hexal AG Corporation Information
12.6.2 Hexal AG Description and Business Overview
12.6.3 Hexal AG Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Hexal AG Weight Loss Drugs Products Offered
12.6.5 Hexal AG Recent Development
12.7 National Company For Pharmaceutical Industry
12.7.1 National Company For Pharmaceutical Industry Corporation Information
12.7.2 National Company For Pharmaceutical Industry Description and Business Overview
12.7.3 National Company For Pharmaceutical Industry Sales, Revenue and Gross Margin (2015-2020)
12.7.4 National Company For Pharmaceutical Industry Weight Loss Drugs Products Offered
12.7.5 National Company For Pharmaceutical Industry Recent Development
12.8 Lunan Pharmaceutical Group Corporation
12.8.1 Lunan Pharmaceutical Group Corporation Corporation Information
12.8.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
12.8.3 Lunan Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lunan Pharmaceutical Group Corporation Weight Loss Drugs Products Offered
12.8.5 Lunan Pharmaceutical Group Corporation Recent Development
12.9 Zein Pharmaceutical
12.9.1 Zein Pharmaceutical Corporation Information
12.9.2 Zein Pharmaceutical Description and Business Overview
12.9.3 Zein Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Zein Pharmaceutical Weight Loss Drugs Products Offered
12.9.5 Zein Pharmaceutical Recent Development
12.10 Hisun
12.10.1 Hisun Corporation Information
12.10.2 Hisun Description and Business Overview
12.10.3 Hisun Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hisun Weight Loss Drugs Products Offered
12.10.5 Hisun Recent Development
12.11 Roche
12.11.1 Roche Corporation Information
12.11.2 Roche Description and Business Overview
12.11.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Roche Weight Loss Drugs Products Offered
12.11.5 Roche Recent Development
12.12 Kabir Life Sciences & Research
12.12.1 Kabir Life Sciences & Research Corporation Information
12.12.2 Kabir Life Sciences & Research Description and Business Overview
12.12.3 Kabir Life Sciences & Research Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Kabir Life Sciences & Research Products Offered
12.12.5 Kabir Life Sciences & Research Recent Development
12.13 Dm Pharma
12.13.1 Dm Pharma Corporation Information
12.13.2 Dm Pharma Description and Business Overview
12.13.3 Dm Pharma Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Dm Pharma Products Offered
12.13.5 Dm Pharma Recent Development
12.14 China Zhongshan Pharm
12.14.1 China Zhongshan Pharm Corporation Information
12.14.2 China Zhongshan Pharm Description and Business Overview
12.14.3 China Zhongshan Pharm Sales, Revenue and Gross Margin (2015-2020)
12.14.4 China Zhongshan Pharm Products Offered
12.14.5 China Zhongshan Pharm Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Weight Loss Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Weight Loss Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Weight Loss Drugs Market Segments
Table 2. Ranking of Global Top Weight Loss Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Weight Loss Drugs Market Size Growth Rate by Type 2020-2026 (K Tablets) & (US$ Million)
Table 4. Major Manufacturers of Liauid
Table 5. Major Manufacturers of Tablets
Table 6. Global Weight Loss Drugs Market Size Growth Rate by Application 2020-2026 (K Tablets)
Table 7. Global Weight Loss Drugs Market Size by Region (K Tablets) & (US$ Million): 2020 VS 2026
Table 8. Global Weight Loss Drugs Sales by Regions 2015-2020 (K Tablets)
Table 9. Global Weight Loss Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Weight Loss Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Weight Loss Drugs Sales Forecast by Region (2021-2026) (K Tablets)
Table 12. Global Weight Loss Drugs Sales by Manufacturers (2015-2020) (K Tablets)
Table 13. Global Weight Loss Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Weight Loss Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Weight Loss Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Drugs as of 2019)
Table 16. Weight Loss Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Weight Loss Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Weight Loss Drugs Price (2015-2020) (USD/Tablet)
Table 19. Weight Loss Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Weight Loss Drugs Product Type
Table 21. Date of International Manufacturers Enter into Weight Loss Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Weight Loss Drugs Sales by Type (2015-2020) (K Tablets)
Table 24. Global Weight Loss Drugs Sales Share by Type (2015-2020)
Table 25. Global Weight Loss Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Weight Loss Drugs Revenue Share by Type (2015-2020)
Table 27. Weight Loss Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Tablet)
Table 28. Global Weight Loss Drugs Sales Share by Type (2021-2026)
Table 29. Global Weight Loss Drugs Sales by Application (2015-2020) (K Tablets)
Table 30. Global Weight Loss Drugs Sales Share by Application (2015-2020)
Table 31. Global Weight Loss Drugs Sales Share by Application (2021-2026)
Table 32. Global Weight Loss Drugs Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Weight Loss Drugs Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Weight Loss Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Weight Loss Drugs Sales (K Tablets) of Key Companies (2015-2020)
Table 36. Japan Weight Loss Drugs Sales Share by Company (2015-2020)
Table 37. Japan Weight Loss Drugs Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Weight Loss Drugs Sales (K Tablets) by Type (2015-2020)
Table 39. Japan Weight Loss Drugs Sales Share by Type (2015-2020)
Table 40. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Weight Loss Drugs Price (K Tablets) by Type (2015-2020)
Table 42. Japan Weight Loss Drugs Sales (K Tablets) by Type (2021-2026)
Table 43. Japan Weight Loss Drugs Sales Share by Type (2021-2026)
Table 44. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Weight Loss Drugs Revenue Share by Type (2021-2026)
Table 46. Japan Weight Loss Drugs Price (K Tablets) by Type (2021-2026)
Table 47. Japan Weight Loss Drugs Sales (K Tablets) by Application (2015-2020)
Table 48. Japan Weight Loss Drugs Sales Share by Application (2015-2020)
Table 49. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Weight Loss Drugs Sales (K Tablets) by Application (2021-2026)
Table 51. Japan Weight Loss Drugs Sales Share by Application (2021-2026)
Table 52. Japan Weight Loss Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Weight Loss Drugs Revenue Share by Application (2021-2026)
Table 54. North America Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 55. North America Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 56. North America Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 58. Europe Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 59. Europe Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 60. Europe Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Weight Loss Drugs Sales by Region (2015-2020) (K Tablets)
Table 63. Asia Pacific Weight Loss Drugs Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Weight Loss Drugs Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Weight Loss Drugs Revenue Market Share by Region (2015-2020)
Table 66. Latin America Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 67. Latin America Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Weight Loss Drugs Sales by Country (2015-2020) (K Tablets)
Table 71. Middle East and Africa Weight Loss Drugs Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Weight Loss Drugs Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country (2015-2020)
Table 74. Roche Corporation Information
Table 75. Roche Description and Business Overview
Table 76. Roche Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 77. Roche Weight Loss Drugs Product
Table 78. Roche Recent Development
Table 79. GSK group Corporation Information
Table 80. GSK group Description and Business Overview
Table 81. GSK group Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 82. GSK group Product
Table 83. GSK group Recent Development
Table 84. Teva Corporation Information
Table 85. Teva Description and Business Overview
Table 86. Teva Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 87. Teva Product
Table 88. Teva Recent Development
Table 89. Sandoz(Novartis) Corporation Information
Table 90. Sandoz(Novartis) Description and Business Overview
Table 91. Sandoz(Novartis) Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 92. Sandoz(Novartis) Product
Table 93. Sandoz(Novartis) Recent Development
Table 94. STADA-VN J.V.Co., Ltd Corporation Information
Table 95. STADA-VN J.V.Co., Ltd Description and Business Overview
Table 96. STADA-VN J.V.Co., Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 97. STADA-VN J.V.Co., Ltd Product
Table 98. STADA-VN J.V.Co., Ltd Recent Development
Table 99. Hexal AG Corporation Information
Table 100. Hexal AG Description and Business Overview
Table 101. Hexal AG Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 102. Hexal AG Product
Table 103. Hexal AG Recent Development
Table 104. National Company For Pharmaceutical Industry Corporation Information
Table 105. National Company For Pharmaceutical Industry Description and Business Overview
Table 106. National Company For Pharmaceutical Industry Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 107. National Company For Pharmaceutical Industry Product
Table 108. National Company For Pharmaceutical Industry Recent Development
Table 109. Lunan Pharmaceutical Group Corporation Corporation Information
Table 110. Lunan Pharmaceutical Group Corporation Description and Business Overview
Table 111. Lunan Pharmaceutical Group Corporation Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 112. Lunan Pharmaceutical Group Corporation Product
Table 113. Lunan Pharmaceutical Group Corporation Recent Development
Table 114. Zein Pharmaceutical Corporation Information
Table 115. Zein Pharmaceutical Description and Business Overview
Table 116. Zein Pharmaceutical Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 117. Zein Pharmaceutical Product
Table 118. Zein Pharmaceutical Recent Development
Table 119. Hisun Corporation Information
Table 120. Hisun Description and Business Overview
Table 121. Hisun Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 122. Hisun Product
Table 123. Hisun Recent Development
Table 124. Taj Pharmaceuticals Ltd Corporation Information
Table 125. Taj Pharmaceuticals Ltd Description and Business Overview
Table 126. Taj Pharmaceuticals Ltd Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 127. Taj Pharmaceuticals Ltd Product
Table 128. Taj Pharmaceuticals Ltd Recent Development
Table 129. Kabir Life Sciences & Research Corporation Information
Table 130. Kabir Life Sciences & Research Description and Business Overview
Table 131. Kabir Life Sciences & Research Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 132. Kabir Life Sciences & Research Product
Table 133. Kabir Life Sciences & Research Recent Development
Table 134. Dm Pharma Corporation Information
Table 135. Dm Pharma Description and Business Overview
Table 136. Dm Pharma Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 137. Dm Pharma Product
Table 138. Dm Pharma Recent Development
Table 139. China Zhongshan Pharm Corporation Information
Table 140. China Zhongshan Pharm Description and Business Overview
Table 141. China Zhongshan Pharm Weight Loss Drugs Sales (K Tablets), Revenue (US$ Million), Price (USD/Tablet) and Gross Margin (2015-2020)
Table 142. China Zhongshan Pharm Product
Table 143. China Zhongshan Pharm Recent Development
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Weight Loss Drugs Players
Table 148. Weight Loss Drugs Customers List
Table 149. Weight Loss Drugs Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Weight Loss Drugs Product Picture
Figure 2. Global Weight Loss Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Liauid Product Picture
Figure 4. Tablets Product Picture
Figure 5. Global Weight Loss Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Weight-reducing Aid
Figure 7. Other
Figure 8. Weight Loss Drugs Report Years Considered
Figure 9. Global Weight Loss Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Weight Loss Drugs Sales 2015-2026 (K Tablets)
Figure 11. Global Weight Loss Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Weight Loss Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Weight Loss Drugs Sales Market Share by Region in 2019
Figure 14. Global Weight Loss Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Weight Loss Drugs Revenue Market Share by Region in 2019
Figure 16. Global Weight Loss Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Weight Loss Drugs Revenue in 2019
Figure 18. Weight Loss Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Weight Loss Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Weight Loss Drugs Sales Market Share by Type in 2019
Figure 21. Global Weight Loss Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Weight Loss Drugs Revenue Market Share by Type in 2019
Figure 23. Global Weight Loss Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Weight Loss Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Weight Loss Drugs Sales Market Share by Application in 2019
Figure 26. Global Weight Loss Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Weight Loss Drugs Revenue Market Share by Application in 2019
Figure 28. Japan Weight Loss Drugs Sales Growth Rate 2015-2026 (K Tablets)
Figure 29. Japan Weight Loss Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. Japan Weight Loss Drugs Market Share in Global Market 2015-2026
Figure 31. Japan 5 and 10 Largest Weight Loss Drugs Players Market Share by Revenue in Weight Loss Drugs in 2019
Figure 32. Japan Weight Loss Drugs Revenue Share by Type (2015-2020)
Figure 33. Japan Weight Loss Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Japan Weight Loss Drugs Revenue Share by Application (2015-2020)
Figure 35. Japan Weight Loss Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 37. North America Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Weight Loss Drugs Sales Market Share by Country in 2019
Figure 39. North America Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 41. U.S. Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 43. Canada Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 45. Europe Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Weight Loss Drugs Sales Market Share by Country in 2019
Figure 47. Europe Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 49. Germany Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 51. France Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 53. U.K. Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 55. Italy Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 57. Russia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Asia Pacific Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 59. Asia Pacific Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Weight Loss Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Weight Loss Drugs Revenue Market Share by Region in 2019
Figure 62. China Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 63. China Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 65. Japan Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 67. South Korea Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 69. India Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 71. Australia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 73. Taiwan Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 75. Indonesia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 77. Thailand Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 79. Malaysia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 81. Philippines Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 83. Vietnam Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Latin America Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 85. Latin America Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Weight Loss Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 89. Mexico Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 91. Brazil Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 93. Argentina Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Middle East and Africa Weight Loss Drugs Sales Growth Rate 2015-2020 (K Tablets)
Figure 95. Middle East and Africa Weight Loss Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Weight Loss Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Weight Loss Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 99. Turkey Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 101. Saudi Arabia Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Weight Loss Drugs Sales Growth Rate (2015-2020) (K Tablets)
Figure 103. U.A.E Weight Loss Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Porter's Five Forces Analysis
Figure 105. Weight Loss Drugs Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110.
  • Global and China Anti-Suicide Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 134
    Anti-Suicide Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Suicide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Anti-Suicide Drug market is segmented......
  • Global and United States Animal Generic Drug Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 143
    Animal Generic Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Animal Generic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Animal Generic Drug market is seg......
  • Global and China Contrast Agents for Magnetic Resonance Imaging (MRI) Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 147
    Contrast Agents for Magnetic Resonance Imaging (MRI) market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Contrast Agents for Magnetic Resonance Imaging (MRI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.......
  • Global and China Coagulation Factor Concentrates Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 148
    Coagulation Factor Concentrates market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Coagulation Factor Concentrates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Coagulati......
  • Global and United States Amyloidosis Therapeutics Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 149
    Amyloidosis Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Amyloidosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Amyloidosis Therapeutic......
  • Global and China Meniere Disease Drugs Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 133
    Meniere Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Meniere Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Meniere Disease Drugs market ......
  • Global and United States Melanocyte Stimulating Hormone Receptor Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 131
    Melanocyte Stimulating Hormone Receptor market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Melanocyte Stimulating Hormone Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Typ......
  • Global and Japan Nicotinamide Phosphoribosyltransferase Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 134
    Nicotinamide Phosphoribosyltransferase market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Nicotinamide Phosphoribosyltransferase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type,......
  • Global and Japan Kidney Transplant Rejection Therapeutics Market Insights, Forecast to 2026
    Published: 28-Oct-2020        Price: US 3900 Onwards        Pages: 141
    Kidney Transplant Rejection Therapeutics market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Kidney Transplant Rejection Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by T......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs